Emmanuel Antonarakis – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailanton401umnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

3 Finished
10 Active

10 results

Filter

Active
Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors
Miller, J. S., Antonarakis, E., Chen, C. C., Cichocki, F. M., Davis, Z. B., Dehm, S. M., Felices, M., Luo, X. & Provenzano, P.
NIH NATIONAL CANCER INSTITUTE (NCI)
8/1/23 → 7/31/30
Project: Research project
A Phase 2/3, Randomized, Open-label, Study of MGC018 Versus Androgen Receptor Axis-targeted Therapy (Abiraterone or Enzalutamide) in Participants with Metastatic Castration-resistant Prostate Cancer
Antonarakis, E.
MACROGENICS INC
11/3/22 → 11/3/27
Project: Research project
Prostate Cancer Research Program, Clinical Consortium Award: University of Minnesota Masonic Cancer Center
Antonarakis, E. & Ryan, C.
US DEPT OF DEFENSE ARMY
9/30/22 → 9/29/24
Project: Research project
A Randomized Phase II Study Comparing Sequential High dose Testosterone andEnzalutamide to Enzalutamide alone in Asymptomatic Men with Castration ResistantMetastatic Prostate Cancer
Antonarakis, E.
JOHNS HOPKINS UNIVERSITY, US DEPT OF DEFENSE ARMY
9/1/22 → 3/31/24
Project: Research project
A Randomized Phase II Study Comparing Sequential HighDose Testosterone and Enzalutamide to Enzalutamide alone inAsymptomatic Men with Castration Resistant Metastatic Prostate Cancer:The STEP-UP Trial (Sequential Testosterone and Enzalutamide Prevents
Antonarakis, E.
JOHNS HOPKINS UNIVERSITY, ASTELLAS PHARMA, INC
9/1/22 → 4/30/26
Project: Research project
PSMAddition: An International Prospective Open-label,Randomized, Phase III Study comparing 177Lu-PSMA-617in combination with Standard of Care, versus Standard ofCare alone, in adult male patients with Metastatic HormoneSensitive Prostate Cancer (mHSP
Antonarakis, E.
NOVARTIS PHARMACEUTICALS CORPORATION
1/18/22 → 1/31/27
Project: Research project
SAFETY AND PHARMACOKINETICS OF ODM-208 IN PATIENTS WITH METASTATICCASTRATION-RESISTANT PROSTATE CANCER
Antonarakis, E.
ORION CORPORATION
10/8/21 → 10/31/26
Project: Research project
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone (A Phase 2 Study of Carboplatin, Cabazitaxel and Abiraterone in Metastatic Castrate Sensitive Prostate Cancer with and without DNA repair mutations)
Antonarakis, E. & Ryan, C.
PROSTATE CANCER CLINTRIAL CONSORTIUM LLC, GENZYME CORPORATION
1/1/19 → 5/30/25
Project: Research project
A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Antonarakis, E., Rao, A. & Ryan, C.
ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY, JANSSEN PHARMACEUTICALS, INC.
4/1/18 → 4/30/26
Project: Research project
A phase 1b dose-escalation and dose-expansion study of e
Antonarakis, E., Gupta, S. & Rao, A.
SEAGEN INC
12/1/17 → 12/31/23
Project: Research project